Autoimmune liver disease

Current Opinion in Gastroenterology

Volumn 17, Issue 3, 2001, Pages 268-275

  Czaja, Albert J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CYTOCHROME P450 2D6; HLA DR ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; SELENOCYSTEINE;

ANTIGEN DETECTION; AUTOIMMUNE DISEASE; CELL DEATH; CHRONIC DISEASE; CLINICAL FEATURE; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; DISEASE MARKER; DISEASE PREDISPOSITION; DRUG RESPONSE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; LIVER CELL; LIVER DISEASE; PATHOGENESIS; REVIEW; RISK FACTOR; SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY;

EID: 0035045760     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200105000-00010     Document Type: Review

References (39)

1. Neonatal sclerosing cholangitis associated with autoimmune phenomena
2. Wilson's disease with superimposed autoimmune features: Report of two cases and review
3. Sweet's syndrome in association with probable autoimmune hepatitis
4. Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis
5. Hepatocellular carcinoma complicating HCV-negative autoimmune hepatitis without corticosteroid therapy
6. Hepatocellular carcinoma in autoimmune hepatitis
7. Serum soluble HLA-DR antigens in autoimmune hepatitis
8. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis
9. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis
10. Pediatric and adult forms of type 1 autoimmune hepatitis in Argentina: Evidence for differential genetic predisposition
11. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis
12. Minocycline and autoimmunity
13. Autoimmune hepatitis in a genetically susceptible patient. Is it triggered by acute hepatitis A?
14. Epstein-Barr virus infection resembling autoimmune hepatitis with lactate dehydrogenase and alkaline phosphatase anomaly
15. Hepatitis C virus, autoimmunity and lymphoproliferation
16. Autoimmune hepatitis
17. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis
18. Swedish Intern Med Liver Club: Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: Prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease
19. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases
20. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
21. (Ser)Sec complex recognized by autoantibodies from patients with type 1 autoimmune hepatitis
22. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes
23. Liver/kidney microsomal antibody type 1 targets CYP2D6 on the hepatocyte plasma membrane
24. Target proteins in human autoimmunity: Cytochromes P450 and UDP-glucuronosyltransferases
25. Nature and behavior of serum cytokines in type 1 autoimmune hepatitis
26. + T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena
27. In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes
28. Fas and Fas ligand in gut and liver
29. Autoimmune disease overlaps and the liver: Two for the price of one?
30. Autoimmune cholangitis within the spectrum of autoimmune liver disease
31. Autoimmune cholangitis with features of autoimmune hepatitis: Successful treatment with immunosuppressive agents and ursodeoxycholic acid
32. Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis
33. Autoimmune forms of chronic hepatitis associated with hepatitis C virus (HCV) infection with and without HCV-RNA: Histologic differences from pure autoimmune hepatitis and chronic hepatitis C
34. Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection
35. Treatment of autoimmune and extra-hepatic manifestations of HCV infection
36. Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
37. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine
38. Autoimmune hepatitis: The investigational and clinical challenges
39. Liver transplantation in autoimmune liver disease: Selection of patients